Stago Group News

Stago introduces a new flow analysis service: MyOptiLab

The new MyOptiLab workflow analysis service is part of a broader strategy aimed at working more closely with laboratories. It is an elaborate process designed to optimise organisational excellence.

Read more

World Health Day 2021. Health for all!

7 April is World Health Day. As the pandemic lingers on, health issues as well as health-related local, national and international governance issues have never been more at the forefront of public attention and concerns.

Read more

COVID-19 infection and thrombotic disorders

Since December 2019, a new type of pneumonia defined as coronavirus disease 2019 (COVID-19) is spreading worldwide and affecting an increasing number of people every day. Main symptoms are fever and cough, and most of patients...

Read more

Health Economics Outcomes evaluation of Stago D-dimer

Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.

Read more

FDA grants de novo for the HemoSonics’ Quantra System

March 13, 2019 : Stago is proud to announce that HemoSonics, a Stago Group company, has been granted de novo marketing authorization by the FDA for its revolutionary diagnostic device Quantra Hemostasis Analyzer platform, and its...

Read more

 1 2 3 4 5 6 7